Compare VALN & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | EVER |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 855.8M | 929.5M |
| IPO Year | 2021 | 2018 |
| Metric | VALN | EVER |
|---|---|---|
| Price | $10.30 | $23.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $15.75 | ★ $33.00 |
| AVG Volume (30 Days) | 19.5K | ★ 389.8K |
| Earning Date | 11-20-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 284.14 |
| EPS | N/A | ★ 1.44 |
| Revenue | $211,089,992.00 | ★ $644,656,000.00 |
| Revenue This Year | $3.64 | $37.47 |
| Revenue Next Year | $12.23 | $14.11 |
| P/E Ratio | ★ N/A | $16.43 |
| Revenue Growth | 13.48 | ★ 57.83 |
| 52 Week Low | $4.56 | $17.35 |
| 52 Week High | $12.25 | $30.03 |
| Indicator | VALN | EVER |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 35.27 |
| Support Level | $9.62 | $23.58 |
| Resistance Level | $10.32 | $25.12 |
| Average True Range (ATR) | 0.30 | 0.98 |
| MACD | 0.03 | -0.24 |
| Stochastic Oscillator | 62.50 | 5.41 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.